Diagnostics

Across three studies, researchers demonstrated how various biomarkers can inform trial design and predict lymphoma patients' outcomes on CAR T-cell therapy.

At ASH, researchers reported that a PGx-based score could identify the cytarabine-based induction therapy young Black patients are most likely to benefit from.

The firm is offering molecular diagnostic testing and clinical trial services to bridge knowledge gaps and increase access to personalized care locally.